- Home
- NECB vs RCKT Comparison
NECB vs RCKT Comparison
Compare NECB & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NECB | RCKT |
|---|---|---|
| Founded | 1934 | 1999 |
| Country | United States | United States |
| Employees | N/A | 202 |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 337.9M | 401.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | NECB | RCKT |
|---|---|---|
| Price | $24.38 | $3.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 14 |
| Target Price | ★ $30.00 | $29.73 |
| AVG Volume (30 Days) | 21.1K | ★ 2.0M |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | ★ 4.12% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.85 | N/A |
| Revenue Next Year | $8.45 | $64.28 |
| P/E Ratio | $32.84 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.27 | $2.40 |
| 52 Week High | $25.65 | $5.45 |
Technical Indicators
Market Signals| Indicator | NECB | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 55.62 | 37.70 |
| Support Level | $22.71 | $3.02 |
| Resistance Level | $25.07 | $3.52 |
| Average True Range (ATR) | 0.50 | 0.21 |
| MACD | 0.08 | -0.03 |
| Stochastic Oscillator | 84.56 | 14.68 |
Price Performance
Historical ComparisonAbout NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States, including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.